Article
Unraveling germline predisposition in hematological neoplasms: Navigating complexity in the genomic era.
Blood reviews - 1 Mar 2024
Jerez Joaquín, Santiago Marta
Abstract excerpt
Genomic advancements have yielded pivotal insights into hematological neoplasms, particularly concerning germline predisposition mutations. Following the WHO 2016 revisions, dedicated segments were proposed to address these aspects. Current WHO 2022, ICC 2022, and ELN 2022 classifications recognize their significance, introducing more mutations and prompting integration into clinical practice. Approximately 5-10%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
